Sandra Poole

Sandra joined Mythic Therapeutics in July 2020 as Chief Operating Officer, bringing with her more than 25 years of experience in executive and operating roles in the biopharma industry within areas of global drug development, technical operations, company building, and general management. Prior to Mythic, Sandra served as the COO of LogicBio Therapeutics, a pre-clinical stage biotech company. She also held executive roles of increasing responsibility at ImmunoGen, Inc., culminating with Executive Vice President of Technical Operations and Commercial Development.

Sandra also spent more than 15 years at Genzyme Corporation and at Sanofi (after the acquisition of Genzyme) in various roles, including Senior Vice President of Global Biologics Manufacturing and Vice President and General Manager of Genzyme Flanders, NV/SA in Belgium. She currently serves on the board of directors of Travere Therapeutics and Viacyte, Inc and was formerly on the supervisory board for Valneva, SE. Sandra holds a MASc and BASc in chemical engineering from the University of Waterloo, Canada.